May 17, 2023 - May 19, 2023

Remus Pharmaceuticals IPO Subscription Details

Remus Pharmaceuticals IPO Subscription Status Live

Remus Pharmaceuticals IPO subscribed 57.21 times. The public issue subscribed 49.81 times in the retail category, 10.75 times in QIB, and 229.31 times in the NII category by May 19, 2023 (Day 3).

Investor Category	Subscription (times)	Shares Offered	Shares Bid for	Total Amount (Rs Cr.)*
Qualified Institutions	10.75	138,750	14,92,000	183.37
Non-Institutional Buyers	229.31	41,625	95,45,000	1,173.08
Retail Investors	49.81	97,125	48,37,600	594.54
Employees	[.]	0	0	0
Others	[.]	0	0	0
Total	57.21	277,500	1,58,74,600	1,950.99

Total Application : 48,376 (49.77 times)

Disclaimer: *The total amount is calculated based on the final issue price or the price in the upper price range.

* Market Maker portion of 19,500 equity shares not included.

Remus Pharmaceuticals IPO (Day-wise) Subscription Details (times)

Date	QIB	NII	Retail	Total
Day 1 May 17, 2023	0.00	2.85	2.85	1.43
Day 2 May 18, 2023	1.48	12.25	10.93	6.41
Day 3 May 19, 2023	10.75	229.31	49.81	57.21

Remus Pharmaceuticals IPO Shares Offered

Remus Pharmaceuticals IPO is a public issue of 407,500 equity shares. The issue offers 97,125 shares to retail investors, 138,750 shares to qualified institutional buyers, and 41,625 shares to non-institutional investors.

Category	Shares Offered	Amount (Rs Cr)	Size (%)
Anchor Investor	110,500	13.58	27.12%
Market Maker	19,500	2.40	4.79%
QIB	138,750	17.05	34.05%
NII	41,625	5.12	10.21%
Retail	97,125	11.94	23.83%
Total	407,500	50.08	100%

Remus Pharmaceuticals IPO Anchor Investor Allocation

A total of 110,500 shares at a price of Rs 1,229 per share will be allotted to the anchor investors.

S.No.	Name of Anchor Investor	No. of Shares Allocated	Bid Price Per Share (Rs.)	Anchor Investor Portion (%)	Total Amount Allocated (Rs.)
1	Chhattisgarh Investments Limited	101,700	1,229	92.04	124,989,300
2	Nav Capital Vcc- Nav Capital Emerging Star Fund	8,800	1,229	7.96	10,815,200
		110,500		100	135,804,500

IPO Investor Categories

Qualified Institutional Buyers (QIB)
Financial Institutions, Banks, FIIs, and Mutual Funds registered with SEBI are called QIBs. In most cases, QIBs represent small investors who invest through mutual funds, ULIP schemes of insurance companies, and pension schemes.
Non-Institutional Investors(NII)
Retail Individual Investors (HNI), NRIs, Companies, Trusts, etc who bid for shares worth more than Rs 2 lakhs are known as Non-institutional bidders (NII). Unlike QIB bidders, they do not need SEBI registration.
NII category has two subcategories:
1. sNII (bids below Rs 10L)
  The Small NII category is for NII investors who bid for shares between Rs 2 lakhs to Rs 10 lakhs. The 1/3 of NII category shares are reserved for the Small NII sub-category. This subcategory is also known as Small HNI (sHNI).
2. bNII (bids above Rs 10L)
  The Big NII category is for NII investors who bid for shares worth more than Rs 10 Lakhs. The 2/3 of NII category shares are reserved for the Big NII subcategory. This subcategory is also known as Big HNI (bHNI).
Retail Individual Investors(RII)
The retail individual investor or NRIs who apply up to Rs 2 lakhs in an IPO are considered as RII reserved category.
Employee (EMP)
A category of eligible employees who have a reserved quota in the IPO.
Others
A category of eligible shareholders or other investors who have a reserved quota in the IPO.

What is the difference between RII, NII, QIB and Anchor Investor?

Disclaimer: The above information / data is sourced from National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) websites and is subject to change in real time. For latest information / data, please refer to the respective websites. The information / data provided here in is for informational purposes only and is provided by Chittorgarh.com on "AS IS" and "AS AVAILABLE" basis and without warranty, express or implied. Chittorgarh.com does not warrant the accuracy, adequacy or completeness of the information you obtain through the above websites. Chittorgarh.com shall not be liable in any way for any discrepancies, errors, omissions, losses or damage. Chittorgarh.com, including its affiliates and its directors, staff and employees, shall not be liable for any loss, damage of any kind, including but not limited to direct, indirect, punitive, exemplary, consequential damages and lost profits arising in any way out of the use of information / data obtained through the said websites. The recipient alone is fully responsible / liable for any decision made based on this information / data. All recipients, before relying on the said information, should do their own research and seek appropriate professional advice.

Remus Pharmaceuticals IPO Subscription FAQs

The Remus Pharmaceuticals IPO is subscribed 57.21 by May 19, 2023.